Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights| (NASDAQ: DNLI) | Delayed: 23.80 +0.49 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.31 | 52 Week High | $ | |||
| Open | $23.90 | 52 Week Low | $ | |||
| Day High | $24.34 | P/E | N/A | |||
| Day Low | $23.66 | EPS | $ | |||
| Volume | 404,762 | |||||

